Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Foamix Stock Just Dropped 27.5%


Shares of Foamix Pharmaceuticals (NASDAQ: FOMX) stock crashed in early trading Monday after the Israeli dermatological treatment company announced an agreement to acquire the competing, revenue-less pharmaceutical products business Menlo Therapeutics (NASDAQ: MNLO) in an all-stock transaction.

Shares of Foamix are down 27.5% as of 10:40 a.m. EST in response to the news, and Menlo's not looking too healthy itself -- down 8.4%.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments